Search results
Psychedelic drug MDMA faces questions as FDA considers approval for PTSD
WDTV· 2 hours agoFederal health regulators are questioning the safety and evidence behind the first bid to use MDMA,...
The FDA is weighing whether to approve MDMA for PTSD. Here's what that could look like for patients.
CBS News· 2 hours agoAhead of a key meeting Tuesday to weigh the potential approval of midomafetamine, or MDMA, for...
F.D.A.’s Review of MDMA Cites Health Risks and Study Flaws
New York Times· 3 hours agoThe Food and Drug Administration on Friday raised concerns about the health effects of MDMA as a...
US FDA staff raises concerns over data from MDMA-based PTSD therapy
Reuters via Yahoo News· 8 hours ago(Reuters) -The U.S. health regulator's staff said on Friday data on the psychedelic drug MDMA for...
FDA staff outline shortcomings of Lykos data for MDMA therapy
BioPharma Dive via Yahoo Finance· 9 hours agoAhead of an advisory panel meeting, agency staff identified several sticking points in the clinical...
FDA staff questions safety of ecstasy for PTSD
Axios· 3 hours agoWhy it matters: The findings cast new doubts on what could become the first psychedelic-based treatment approved in the U.S. ahead of a June 4 meeting...
What is MDMA? | National Institute on Drug Abuse
Mountain View Telegraph· 16 hours agoMDMA is a synthetic drug that acts as a stimulant and hallucinogen.15–17 It produces an energizing effect, distortions in time and perception, and enhanced enjoyment from ...
Psychoactive drugs like ketamine and MDMA are having a moment. The FDA will soon weigh in.
CBS News· 3 days agoLori Tipton is among the growing number of people who say that MDMA, also known as ecstasy, saved...
Research confirms the therapeutic potential of MDMA, ketamine, and psilocybin to help people with...
American Psychological Association· 5 hours agoAn estimated 40%–60% of people with post-traumatic stress disorder (PTSD) do not respond to the...
US FDA staff flags concerns on MDMA-assisted PTSD treatment
Reuters· 8 hours agoThe U.S. health regulator's staff reviewers on Friday raised concerns related to interpretation of...